Compare GSK plc (GSK) vs GraniteShares 2x Long NVDA Daily ETF (NVDL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs GraniteShares 2x Long NVDA Daily ETF — how do they compare? GSK plc trades at $52.82 (market cap $101.34B), while GraniteShares 2x Long NVDA Daily ETF trades at $31.53. The key difference: GSK plc pays a 3.49% dividend while GraniteShares 2x Long NVDA Daily ETF pays none, and GSK plc is trading nearer its 52-week high, GraniteShares 2x Long NVDA Daily ETF nearer its low. Which is the better fit depends on your goals.
| GSK | NVDL | |
|---|---|---|
Market Cap | $101.34B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $61.18 | $43.02 |
52-Week Low | $36.20 | $21.76 |
Enterprise Value | $121.95B | — |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $31.635, down 4.63% on the day, reflecting the volatility inherent in leveraged ETFs. The technical picture shows a bullish bias in moving averages but neutral oscillators, with key support at $30 and resistance at $34. Recent corporate actions include two 1:3 stock splits in late June 2026, adjusting share structure.
The outlook for NVDL is heavily tied to NVIDIA's performance, offering amplified daily returns but significant risk from volatility decay. Investment opportunity exists for traders bullish on NVIDIA's AI dominance, but risks include leveraged ETF structural decay and dependence on a single stock's momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About GraniteShares 2x Long NVDA Daily ETF
NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →
